(Q37710152)

22 August 2017

1 reference

title

Expanding the definition of hypothalamic obesity (English)

1 reference

22 August 2017

0 references

I Hochberg

1

1 reference

PubMed ID

20233310

22 August 2017

Z Hochberg

series ordinal

2

1 reference

22 August 2017

1 October 2010

1 reference

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

10

1 reference

22 August 2017

709-721

1 reference

Insulin secretion in hypothalamic obesity: diurnal variation and the effect of naloxone

22 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00727.X

Central melanocortin receptors regulate insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00727.X

The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00727.X

Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00727.X

Treatment of hypothalamic obesity with caffeine and ephedrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00727.X

Central stimulatory effect of leptin on T3 production is mediated by brown adipose tissue type II deiodinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2010.00727.X

10.1111/J.1467-789X.2010.00727.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20233310